Literature DB >> 21184580

Screening of human LPHN3 for variants with a potential impact on ADHD susceptibility.

Sabina Domené1, Horia Stanescu, Deeann Wallis, Bradford Tinloy, Daniel E Pineda, Robert Kleta, Mauricio Arcos-Burgos, Erich Roessler, Maximilian Muenke.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is the most common behavioral disorder in childhood, and often has effects detectable into adulthood. Advances in genetic linkage and association analysis have begun to elucidate some of the genetic factors underlying this complex disorder. Recently, we identified LPHN3, a novel ADHD susceptibility gene harbored in 4q, and showed that a LPHN3 common haplotype confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Here we present the mutational analysis of the entire coding region of LPHN3 in a cohort of 139 ADHD subjects and 52 controls from across the USA. We identified 21 variants, of which 14 have been reported and 7 are novel. These include 5 missense, 8 synonymous, and 8 intronic changes. Interestingly, neither susceptibility nor protective haplotype alleles are associated with obviously significant coding region changes, or canonical splice site alterations, suggesting that non-coding variations determining the quantity and/or quality of LPHN3 isoforms are the likely contributors to this common behavioral disorder.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184580     DOI: 10.1002/ajmg.b.31141

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  31 in total

1.  FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development.

Authors:  Matthew L O'Sullivan; Joris de Wit; Jeffrey N Savas; Davide Comoletti; Stefanie Otto-Hitt; John R Yates; Anirvan Ghosh
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

2.  Knockout of latrophilin-3 in Sprague-Dawley rats causes hyperactivity, hyper-reactivity, under-response to amphetamine, and disrupted dopamine markers.

Authors:  Samantha L Regan; Jillian R Hufgard; Emily M Pitzer; Chiho Sugimoto; Yueh-Chiang Hu; Michael T Williams; Charles V Vorhees
Journal:  Neurobiol Dis       Date:  2019-06-06       Impact factor: 5.996

Review 3.  Mechanisms of adhesion G protein-coupled receptor activation.

Authors:  Alexander Vizurraga; Rashmi Adhikari; Jennifer Yeung; Maiya Yu; Gregory G Tall
Journal:  J Biol Chem       Date:  2020-08-06       Impact factor: 5.157

4.  ADGRL3 rs6551665 as a Common Vulnerability Factor Underlying Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.

Authors:  Djenifer B Kappel; Jaqueline B Schuch; Diego L Rovaris; Bruna S da Silva; Diana Müller; Vitor Breda; Stefania P Teche; Rudimar S Riesgo; Lavínia Schüler-Faccini; Luís A Rohde; Eugenio H Grevet; Claiton H D Bau
Journal:  Neuromolecular Med       Date:  2019-01-16       Impact factor: 3.843

5.  Structural basis for misfolding in myocilin-associated glaucoma.

Authors:  Rebecca K Donegan; Shannon E Hill; Dana M Freeman; Elaine Nguyen; Susan D Orwig; Katherine C Turnage; Raquel L Lieberman
Journal:  Hum Mol Genet       Date:  2014-12-18       Impact factor: 6.150

6.  An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility.

Authors:  Ariel F Martinez; Yu Abe; Sungkook Hong; Kevin Molyneux; David Yarnell; Heiko Löhr; Wolfgang Driever; Maria T Acosta; Mauricio Arcos-Burgos; Maximilian Muenke
Journal:  Biol Psychiatry       Date:  2016-07-14       Impact factor: 13.382

7.  Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).

Authors:  Andreas J Fallgatter; Ann-Christine Ehlis; Thomas Dresler; Andreas Reif; Christian P Jacob; Mauricio Arcos-Burgos; Maximilian Muenke; Klaus-Peter Lesch
Journal:  Eur Neuropsychopharmacol       Date:  2012-12-12       Impact factor: 4.600

8.  Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.

Authors:  Shaunna L Clark; Renan P Souza; Daniel E Adkins; Karolina Aberg; József Bukszár; Joseph L McClay; Patrick F Sullivan; Edwin J C G van den Oord
Journal:  Pharmacogenet Genomics       Date:  2013-02       Impact factor: 2.089

9.  Structural Basis of Latrophilin-FLRT-UNC5 Interaction in Cell Adhesion.

Authors:  Yue C Lu; Olha V Nazarko; Richard Sando; Gabriel S Salzman; Nan-Sheng Li; Thomas C Südhof; Demet Araç
Journal:  Structure       Date:  2015-07-30       Impact factor: 5.006

10.  Structural and Mechanistic Insights into the Latrophilin3-FLRT3 Complex that Mediates Glutamatergic Synapse Development.

Authors:  Fanomezana M Ranaivoson; Qun Liu; Francesca Martini; Francesco Bergami; Sventja von Daake; Sheng Li; David Lee; Borries Demeler; Wayne A Hendrickson; Davide Comoletti
Journal:  Structure       Date:  2015-07-30       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.